利波卡林-2通过mTOR通路激活诱导管细胞中的线粒体功能障碍
Eloïse Marques1, Maraiza Alves Teixeira1, Clément Nguyen1
1Mechanisms and Therapeutic Strategies of Chronic Kidney Disease, INSERM U1151-CNRS UMR 8253, Université Paris Cité, Institut Necker Enfants Malades, 160 Rue de Vaugirard, 75015 Paris, France.
卡林-2 (LCN2) 蛋白在损伤中通过增加mTOR活性驱动线粒体碎片化. 在损伤期间,非激活LCN2可以保持线粒体功能.
科学领域:
- 细胞生物学 细胞生物学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 线粒体生物学 线粒体生物学
背景情况:
- 线粒体功能障碍是损伤的核心,但其调节者是未知的.
- 利波卡林-2 (LCN2) 在受伤的脏管状细胞中被上调.
研究的目的:
- 研究LCN2在调节损伤中的线粒体功能障碍中的作用.
- 阐明LCN2影响线粒体的分子机制.
主要方法:
- 评估LCN2对细胞中的线粒体质量,功能和形态学的影响.
- 研究了DRP1和mTOR信号通路的参与.
- 在体内缺血-再输血损伤模型中利用Lcn2基因缺乏的小鼠.
主要成果:
- LCN2表达减少了线粒体质量和功能,诱导了碎片化.
- LCN2促进了DRP1的招募,并增加了细胞内mTOR活动.
- 拉巴胺素治疗和Lcn2基因失活改善了LCN2诱导的线粒体变化.
结论:
- LCN2是线粒体动力学和损伤中的功能障碍的关键调节者.
- LCN2在细胞内发挥作用,影响mTOR信号传递和线粒体形状.
- 准LCN2可能为涉及线粒体功能障碍的脏疾病提供治疗策略.
更多相关视频
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
10:37Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Chronic Kidney Disease II: Clinical Manifestations
Renal Tubule and Collecting Duct
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
